Drugs / Tcm
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03575806 | Jan 2017 → Oct 2019 | hepatocellular carcinoma | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tcm | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03575806 ↗ |